Appetite suppressants at a glance
Appetite suppressants are drugs, supplements or foods taken to feel less hungry or full sooner. This list covers four kinds of prescription appetite suppressant pills, two supplement categories and one food.
GLP-1 shots sit beside them as a different kind of medicine. In Harbor's GLP-1 programs, a board-certified physician reviews your health history before anything ships, and the plan is designed to end with a clinician-guided taper and registered-dietitian aftercare. The compounded semaglutide and tirzepatide in those programs are not FDA approved.
| Option | What it is | FDA status | What the source reports |
|---|---|---|---|
| Phentermine | Prescription stimulant, Schedule IV | Approved for a few weeks | Only a fraction of a pound a week more than placebo |
| Phentermine-topiramate (Qsymia) | Prescription capsule, Schedule IV | Approved for long-term use | 10.9% vs 1.6% on placebo at one year, top dose |
| Bupropion-naltrexone (Contrave) | Prescription tablet | Approved for long-term use | 5.4% vs 1.3% on placebo at 56 weeks |
| Diethylpropion and phendimetrazine | Prescription stimulants, Schedule IV and III | Approved for a few weeks | A fraction of a pound a week more than placebo |
| Glucomannan and other fiber | Dietary supplement | No FDA review before sale | No significant effect on weight in a 2015 review of six trials |
| Protein | Food | Not a drug | 441 fewer calories a day in a 19-person study |
| Caffeine and green tea extract | Drink or dietary supplement | No FDA review before sale as a supplement | Green tea preparations 0.95 kg more than placebo over 12 to 13 weeks, and no significant difference in trials outside Japan |
Drug rows come from each current FDA label on DailyMed, mean percent weight change in the label's own trial. Supplement rows come from the NIH Office of Dietary Supplements fact sheet, and the protein row from a 2005 University of Washington study.
Appetite suppressants & how each one works
An appetite suppressant can work on the brain, on the stomach or on neither, depending on which one you mean. The seven below start with the prescription drugs, phentermine through diethylpropion and phendimetrazine, then move to glucomannan, protein, and caffeine with green tea extract.
One detail in the fine print is easy to miss. FDA's labels for phentermine, diethylpropion and phendimetrazine each say it has not been established that appetite suppression is the primary way these drugs work in treating obesity.
A product sold as an over the counter appetite suppressant in supplement form has not been reviewed by FDA first. The NIH Office of Dietary Supplements states that, unlike drugs, dietary supplements do not require premarket review or approval by FDA. Its fact sheet also advises talking with a health care provider before using one, especially with high blood pressure, diabetes, or liver or heart disease. Related: GLP-1 supplements compared.
Phentermine
Prescription stimulant, Schedule IV
Phentermine was first approved in the U.S. in 1959. Its FDA label approves it only as a short-term adjunct, a few weeks, alongside exercise, behavior change and a reduced-calorie diet, for people with a BMI of 30 or more, or 27 or more with other risk factors.
Where it wins
What it costs you
A short course, not a long-term plan
Phentermine-topiramate
Daily capsule, Schedule IV
Phentermine-topiramate, sold as Qsymia, pairs phentermine with extended-release topiramate. Unlike phentermine alone, it is approved for long-term use with a reduced-calorie diet and more physical activity, in adults and children 12 and older with obesity and in adults with overweight and at least one weight-related condition.
Where it wins
What it costs you
A long-term pill outside the GLP-1 class
Bupropion-naltrexone
Extended-release tablet
Bupropion-naltrexone, sold as Contrave, combines an antidepressant with an opioid antagonist. Nonclinical studies cited on its label suggest the pair acts on the hypothalamus, the brain's appetite regulatory center, and on the mesolimbic dopamine circuit, its reward system.
Where it wins
What it costs you
A long-term tablet with its own eligibility list
Diethylpropion & phendimetrazine
Stimulants in phentermine's class
Diethylpropion and phendimetrazine sit in the same drug class as phentermine. Both labels approve them only as a short-term adjunct, a few weeks, to a reduced-calorie plan. The diethylpropion label limits it to people with a BMI of 30 or higher who have not responded to diet or exercise alone.
Where it wins
What it costs you
Short-term use only, under a prescriber
Glucomannan & other fiber
Soluble fiber supplement
Glucomannan is a soluble fiber from konjac root that can absorb up to 50 times its weight in water. It has been proposed to increase fullness and slow stomach emptying, but the NIH Office of Dietary Supplements calls its effects on weight loss inconsistent.
Where it wins
What it costs you
Fullness at a meal, not proven weight loss
Protein
Food, not a drug
Protein is the one option here that is already on your plate. In a 2005 University of Washington study, 19 people moved from 15% to 30% of calories from protein with carbohydrate held constant. Satiety rose markedly, and when they could eat freely they took in 441 fewer calories a day.
Where it wins
What it costs you
The food-first place to start
Caffeine & green tea extract
Stimulant & plant extract
Caffeine and green tea extract appear in many weight-loss supplements, yet the NIH fact sheet does not list appetite as how either one works. It describes caffeine as stimulating the central nervous system and raising thermogenesis and fat oxidation, and green tea as raising energy expenditure and fat oxidation.
Where it wins
What it costs you
A drink, not an appetite treatment
Prescription appetite suppressants vs GLP-1 shots
Prescription appetite suppressants and GLP-1 shots reach appetite by different routes. The stimulant pills are sympathomimetic amines. GLP-1 medicines activate the receptor for GLP-1, which the Wegovy label calls a physiological regulator of appetite and caloric intake.
Length of use separates them further. The NIDDK prescription medication guide lists six drugs FDA has approved for long-term use, including the weekly shots Wegovy and Zepbound, and notes that medications such as phentermine are approved only for a few weeks.
| What the label says | Short-term stimulants | Qsymia | Contrave | Brand GLP-1 shots |
|---|---|---|---|---|
| How it is taken | By mouth | Capsule by mouth | Tablet by mouth | Injection once a week |
| Labeled length of use | A few weeks | Long term | Long term | Long term |
| Drug class | Sympathomimetic amine | Phentermine plus topiramate | Opioid antagonist plus antidepressant | GLP-1 receptor agonist (Zepbound also acts on GIP) |
| Controlled substance schedule | Schedule IV, or III for phendimetrazine | Schedule IV | None listed | None listed |
| Label trial result | A fraction of a pound a week more than placebo | 10.9% vs 1.6% on placebo, one year | 5.4% vs 1.3% on placebo, 56 weeks | Wegovy 14.9% vs 2.4%, 68 weeks. Zepbound 15 mg 20.9% vs 3.1%, 72 weeks |
From each current FDA label on DailyMed. These are separate trials with different lengths and populations, not a head-to-head result. The GLP-1 figures are for brand Wegovy and Zepbound. Compounded semaglutide and tirzepatide are not FDA approved and were not the products studied in those trials.
Read the last row with care. A trial average is not a personal forecast.
How to choose an appetite suppressant with a clinician
People searching for how to suppress appetite usually want one answer. A clinician works through several questions in order, and your history settles most of them before your preferences come in.
- Whether medication fits at all. NIDDK says a health care professional may prescribe one for an adult with a BMI of 30 or greater, or 27 or greater with a weight-related health problem such as high blood pressure or type 2 diabetes.
- What your history rules out. A history of cardiovascular disease excludes phentermine, chronic opioid use excludes Contrave, and pregnancy excludes Qsymia. A personal or family history of medullary thyroid carcinoma or MEN 2 excludes Wegovy and Zepbound.
- How long treatment should run. Phentermine, diethylpropion and phendimetrazine are labeled for a few weeks. Qsymia, Contrave and the brand GLP-1 shots are labeled for long-term use.
- When to check progress. NIDDK says that if you have not lost at least 5% of your starting weight after 12 weeks on the full dose, your health care professional will probably advise you to stop.
- What else you take. NIDDK advises telling your prescriber about supplements and vitamins, and not combining weight-loss medications with other weight-loss products unless they are prescribed.
Food stays in the plan whichever option is chosen. NIDDK is plain that medications do not replace physical activity or healthy eating habits.
Pregnancy changes the answer
NIDDK advises never taking a weight management medication during pregnancy or while planning one. A prescriber checks that, your other medicines and your health history before anything is prescribed. For your own situation, message your Harbor clinician.
GLP-1 shots with Harbor
GLP 1 shots through Harbor are a once-weekly injection you give yourself at home, inside a program designed to end. A board-certified physician reviews your intake before anything ships. When you reach your goal, the plan moves to a structured, clinician-guided taper and registered-dietitian aftercare.
Harbor compounded semaglutide starts at $89 a month and compounded tirzepatide at $119, with medication, clinician care and check-ins in one price and no insurance required. Both are compounded drugs, so they are not FDA approved, and neither was the product tested in the Wegovy or Zepbound trials.
Then there is food noise. A 2023 review in the journal Nutrients calls it a colloquial term for rumination and preoccupation with food, drawn from anecdotal reports by patients and clinicians. The Wegovy label never uses the phrase. It says semaglutide decreases calorie intake and that the effect is likely mediated by affecting appetite. Related reading: how food noise changes on tirzepatide.
The prescription pills on this list stay with an in-person prescriber. Harbor does not prescribe phentermine or other Schedule IV controlled substances, and its FAQ says members who want one are referred to in-person obesity-medicine specialists. The weekly shots ship as a vial with U-100 insulin syringes, with 24/7 access to licensed clinicians for medical questions through the patient portal.
If a GLP-1 is not the right fit, it is not prescribed. The online quiz takes about 90 seconds and is the first step toward a physician review.
Medical disclaimer
This article is for general education and is not medical advice. It is not a substitute for evaluation, diagnosis, or treatment by a licensed clinician. Talk with a qualified clinician about your individual situation.
Compounded medications
Harbor is a technology platform. Medical evaluations are conducted by independent, licensed healthcare providers who determine whether treatment is appropriate. Compounded medications are not FDA approved and are not reviewed by the FDA for safety or effectiveness.
Frequently asked questions
Some do, modestly, and it depends on which one. For the short-term prescription pills, the FDA labels answer that people lost only a fraction of a pound a week more than on placebo. Long-term drugs did more in their label trials: Qsymia averaged 10.9% vs 1.6% on placebo at one year, and Contrave 5.4% vs 1.3% at 56 weeks. For supplements, the NIH Office of Dietary Supplements calls the evidence inconclusive and unconvincing.
A natural appetite suppressant is a food or supplement taken to feel fuller, such as protein, a soluble fiber like glucomannan, or green tea. Protein has a small human study behind it: 19 people ate 441 fewer calories a day at 30% protein in 2005. Glucomannan had no significant effect on body weight in a 2015 review of six trials. Supplements also reach the shelf without premarket review or approval by FDA.
In effect, partly, though a GLP-1 is not classed with the older appetite pills. The Wegovy label describes GLP-1 as a physiological regulator of appetite and caloric intake, and says semaglutide decreases calorie intake, likely by affecting appetite. It also delays gastric emptying. Stimulant pills such as phentermine are sympathomimetic amines, a different drug class. A licensed clinician decides whether compounded semaglutide or tirzepatide, which are not FDA approved, is appropriate for you.
Sources
- Phentermine hydrochloride tablets label, DailyMed.
- Qsymia (phentermine and topiramate extended-release) capsules label, revised 03/2026, DailyMed.
- Contrave (naltrexone and bupropion) extended-release tablets label, revised 11/2025, DailyMed.
- Diethylpropion hydrochloride tablets label, DailyMed.
- Phendimetrazine tartrate tablets label, DailyMed.
- Wegovy (semaglutide) injection and tablets label, revised 06/2026, DailyMed.
- Zepbound (tirzepatide) injection label, revised 08/2026, DailyMed.
- Prescription medications to treat overweight & obesity, NIDDK.
- Dietary supplements for weight loss, health professional fact sheet, NIH Office of Dietary Supplements, updated May 18, 2022.
- Weigle DS et al. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight. Am J Clin Nutr. 2005.
- Leidy HJ et al. The role of protein in weight loss and maintenance. Am J Clin Nutr. 2015.
- Hayashi D et al. What is food noise? A conceptual model of food cue reactivity. Nutrients. 2023.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss.






